{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:19:12Z","timestamp":1784225952264,"version":"3.55.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Anovulation is very common and has several different clinical manifestations, including amenorrhea, oligomenorrhea and abnormal uterine bleeding. Various mechanisms can cause anovulation. The clinical consequences and commonest chronic anovulatory disorder, polycystic ovary syndrome (PCOS), has a prevalence that ranges between 6 to 10% of the global population. While multiple causes can eventually result in PCOS, various methods have been described in the literature for its management, often without ascertaining the underlying cause. Ovulation Induction (OI) is a group of techniques that is used in women with PCOS who are looking to conceive and are unbale to do so with natural means. This narrative review presents a summary of the current evidence and available techniques for OI in women with PCOS, highlighting their performance and applicability.<\/jats:p>","DOI":"10.3389\/fmed.2022.982230","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T05:33:51Z","timestamp":1660282431000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Ovulation induction techniques in women with polycystic ovary syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Andreas A.","family":"Vyrides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam","family":"El Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Giannakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstet Gynecol Surv."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-Analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod."},{"key":"B3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.17219\/acem\/59380","article-title":"The pathogenesis and treatment of polycystic ovary syndrome: What's new?","volume":"26","author":"Bednarska","year":"2017","journal-title":"Adv Clin Exp Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2265.1988.tb01208.x","article-title":"episodic pulsatile secretion of fsh, Lh, prolactin, oestradiol, oestrone, and Lh circadian variations in polycystic ovary syndrome","volume":"28","author":"Venturoli","year":"1988","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1210\/jcem.83.7.4925","article-title":"Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics 1","volume":"83","author":"Hayes","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1210\/JCEM.74.5.1569153","article-title":"Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays","volume":"74","author":"Imse","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1210\/jcem-65-2-233","article-title":"Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome","volume":"65","author":"Kazer","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/HUMREP\/16.7.1359","article-title":"Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility","volume":"16","author":"Laven","year":"2001","journal-title":"Hum Reprod."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1210\/JCEM.83.5.4756","article-title":"Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle","volume":"83","author":"Lockwood","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/humrep\/8.suppl_2.123","article-title":"Hypersecretion of luteinizing hormone and the polycystic ovary syndrome","volume":"8","author":"Balen","year":"1993","journal-title":"Hum Reprod."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1210\/jcem.82.7.4105","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome1","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s0015-0282(16)58500-8","article-title":"Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome","volume":"66","author":"Gonzalez","year":"1996","journal-title":"Fertil Steril."},{"key":"B15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0002-9378(91)90280-5","article-title":"Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome","volume":"165","author":"Gonzalez","year":"1991","journal-title":"Am J Obstet Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1210\/jcem-64-5-960","article-title":"Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids","volume":"64","author":"Cohen","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1210\/jcem-67-3-460","article-title":"Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin","volume":"67","author":"Plymate","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/oxfordjournals.humrep.a019512","article-title":"Effects of weight loss on the hormonal profile in obese, infertile women","volume":"11","author":"Hollmann","year":"1996","journal-title":"Hum Reprod."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod."},{"key":"B22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1210\/jcem.82.2.3753","article-title":"17\u03b1-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss 1","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0026-0495(95)90118-3","article-title":"Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome","volume":"44","author":"Andersen","year":"1995","journal-title":"Metabolism."},{"key":"B24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/s0015-0282(16)56632-1","article-title":"Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women","volume":"61","author":"Guzick","year":"1994","journal-title":"Fertil Steril."},{"key":"B25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2265.1989.tb01297.x","article-title":"Diet-Induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I","volume":"31","author":"Kiddy","year":"1989","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0026-0495(97)90303-6","article-title":"Influence of moderate physical exercise on insulin-mediated and non- insulin-mediated glucose uptake in healthy subjects","volume":"46","author":"Ara\u00fajo-Vilar","year":"1997","journal-title":"Metabolism."},{"key":"B28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/apnm-2016-0122","article-title":"Weighing the effects of exercise and intrinsic aerobic capacity: Are there beneficial effects independent of changes in weight?","volume":"41","author":"Thyfault","year":"2016","journal-title":"Appl Physiol Nutr Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod."},{"key":"B30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/s0015-0282(16)46571-4","article-title":"Effect of body weight reduction on plasma androgens in obese, infertile women","volume":"38","author":"Bates","year":"1982","journal-title":"Fertil Steril."},{"key":"B31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejogrb.2004.06.043","article-title":"Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome","volume":"119","author":"Tolino","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/humupd\/dmq045","article-title":"Exercise therapy in polycystic ovary syndrome: a systematic review","volume":"17","author":"Harrison","year":"2011","journal-title":"Hum Reprod Update."},{"key":"B33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejogrb.2015.09.024","article-title":"Results from the international consensus conference on Myo-inositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS","volume":"195","author":"Facchinetti","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1210\/jcem.83.7.4919","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate - End of an era? a mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum Reprod."},{"key":"B36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1210\/jcem.84.5.5705","article-title":"te Velde ER, Habbema JDF, Fauser BCJM. Predictors of Chances to Conceive in Ovulatory Patients during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility1","volume":"84","author":"Imani","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajog.2008.10.031","article-title":"Novel clomiphene \u201cstair-step\u201d protocol reduces time to ovulation in women with polycystic ovarian syndrome","volume":"200","author":"Hurst","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0015-0282(02)04206-1","article-title":"Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: A prospective, double-blind, placebo-controlled trial","volume":"78","author":"Parsanezhad","year":"2002","journal-title":"Fertil Steril."},{"key":"B40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/nejmoa063971","article-title":"Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/nejmoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/oxfordjournals.humrep.a138750","article-title":"Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients","volume":"9","author":"Balen","year":"1994","journal-title":"Hum Reprod."},{"key":"B43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0002-9378(16)32740-5","article-title":"The use of human menopausal and chorionic gonadotropins for induction of ovulation. sixteen years' experience at the Sloane Hospital for Women","volume":"138","author":"Schwartz","year":"1980","journal-title":"Am J Obstet Gynecol."},{"key":"B44","first-page":"189","article-title":"Exogenous gonadotropin therapy in world health organization groups I and II ovulatory disorders","volume":"83","author":"Fluker","year":"1994","journal-title":"Obstet Gynecol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-0528.2003.02290.x","article-title":"Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial","volume":"110","author":"Calaf Alsina","year":"2003","journal-title":"BJOG An Int J Obstet Gynaecol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/HUMUPD\/5.5.493","article-title":"Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements","volume":"5","author":"Homburg","year":"1999","journal-title":"Hum Reprod Update."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/HUMREP\/13.10.2688","article-title":"comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women","volume":"13","author":"Hedon","year":"1998","journal-title":"Hum Reprod."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1210\/JCEM.81.11.8923819","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0015-0282(16)57473-1","article-title":"A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome","volume":"63","author":"Homburg","year":"1995","journal-title":"Fertil Steril."},{"key":"B50","doi-asserted-by":"publisher","first-page":"CD001122","DOI":"10.1002\/14651858.CD001122.pub5","article-title":"Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome","volume":"2","author":"Bordewijk","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/jcem.84.1.5393","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women 1","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00404-003-0537-2","article-title":"The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome","volume":"270","author":"Al-Azemi","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"B54","volume-title":"Speroff's Clinical Gynecologic Endocrinology and Infertility","author":"Taylor","year":"2019"},{"key":"B55","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/REP-16-0385","article-title":"Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS","volume":"153","author":"Jarrett","year":"2017","journal-title":"Reproduction."},{"key":"B56","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0163-7258(81)90055-3","article-title":"The agonistic-antagonistic properties of clomiphene: a review","volume":"15","author":"Clark","year":"1981","journal-title":"Pharmacol Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jama.1961.03040410001001","article-title":"Induction of ovulation with MRL\/41: preliminary report","volume":"178","author":"Greenblatt","year":"1961","journal-title":"JAMA J Am Med Assoc."},{"key":"B58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/humupd\/2.6.483","article-title":"Development, pharmacology and clinical experience with clomiphene citrate","volume":"2","author":"Dickey","year":"1996","journal-title":"Hum Reprod Update."},{"key":"B59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/273057a0","article-title":"Sensitisation of pituitary cells to luteinising hormone releasing hormone by clomiphene citrate in vitro","volume":"273","author":"Hsueh","year":"1978","journal-title":"Nature."},{"key":"B60","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0015-0282(16)60964-0","article-title":"The effect of therapy initiation day on clomiphene citrate therapy","volume":"52","author":"Wu","year":"1989","journal-title":"Fertil Steril."},{"key":"B61","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/s0015-0282(16)46034-6","article-title":"Clinical and laboratory predictors of clomiphene response","volume":"37","author":"Lobo","year":"1982","journal-title":"Fertil Steril."},{"key":"B62","first-page":"196","article-title":"Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation","volume":"62","author":"Hammond","year":"1983","journal-title":"Obstet Gynecol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/oxfordjournals.humrep.a019239","article-title":"Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome","volume":"11","author":"Homburg","year":"1996","journal-title":"Hum Reprod."},{"key":"B64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0015-0282(16)46033-4","article-title":"A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test","volume":"37","author":"Gysler","year":"1982","journal-title":"Fertil Steril."},{"key":"B65","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00006250-197803000-00002","article-title":"Ovulation and pregnancy rates with clomiphene citrate","volume":"51","author":"Gorlitsky","year":"1978","journal-title":"Obstet Gynecol."},{"key":"B66","unstructured":"Approval Package for: Clomid. Application Number NDA 016131\/S-126.2012"},{"key":"B67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmj.288.6410.7","article-title":"Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: Observations on analysis of the normal range","volume":"288","author":"Wathen","year":"1984","journal-title":"Br Med J."},{"key":"B68","first-page":"522","article-title":"Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone","volume":"44","author":"Abraham","year":"1974","journal-title":"Obstet Gynecol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0015-0282(16)45308-2","article-title":"Multiple pregnancies following induction of ovulation","volume":"35","author":"Schenker","year":"1981","journal-title":"Fertil Steril."},{"key":"B70","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/00016347609158516","article-title":"Outcome of Pregnancy After Clomiphene Therapy","volume":"55","author":"Ahlgren","year":"1976","journal-title":"Acta Obstet Gynecol Scand."},{"key":"B71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1479-828X.1982.tb01391.x","article-title":"The outcome of pregnancy resulting from clomiphene-induced ovulation","volume":"22","author":"Correy","year":"1982","journal-title":"Aust New Zeal J Obstet Gynaecol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/humrep\/dex035","article-title":"Endometrial thickness in women undergoing IUI with ovarian stimulation. how thick is too thin? A systematic review and meta-analysis","volume":"32","author":"Weiss","year":"2017","journal-title":"Hum Reprod."},{"key":"B73","first-page":"266","volume":"68","author":"Vital Reyes","year":"2000","journal-title":"Ginecol Obstet Mex"},{"key":"B74","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/s0015-0282(16)58525-2","article-title":"Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: Beneficial effects of the addition of dexamethasone during the follicular phase","volume":"66","author":"Trott","year":"1996","journal-title":"Fertil Steril."},{"key":"B75","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0015-0282(16)47896-9","article-title":"A randomized study of dexamethasone in ovulation induction with clomiphene citrate","volume":"41","author":"Daly","year":"1984","journal-title":"Fertil Steril."},{"key":"B76","first-page":"497","article-title":"Clomiphene and dexamethasone in women unresponsive to clomiphene alone","volume":"60","author":"Lobo","year":"1982","journal-title":"Obstet Gynecol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0015-0282(97)81359-3","article-title":"Extended clomiphene citrate (CC) and prednisone for the treatment of chronic anovulation resistant to CC alone","volume":"67","author":"Isaacs","year":"1997","journal-title":"Fertil Steril."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/humrep\/del053","article-title":"Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study","volume":"21","author":"Elnashar","year":"2006","journal-title":"Hum Reprod."},{"key":"B79","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0015-0282(03)00587-9","article-title":"Adjunctive use of dexamethasome in Clomid resistant patients [5] (multiple letters)","volume":"80","author":"Keay","year":"2003","journal-title":"Fertil Steril."},{"key":"B80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1542\/peds.107.4.e55","article-title":"The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes","volume":"107","author":"Freemark","year":"2001","journal-title":"Pediatrics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1053\/meta.2001.28078","article-title":"Beneficial effects of metformin in normoglycemic morbidly obese adolescents","volume":"50","author":"Kay","year":"2001","journal-title":"Metabolism."},{"key":"B83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1463-1326.2002.00181.x","article-title":"Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity","volume":"4","author":"Gokcel","year":"2002","journal-title":"Diabetes, Obes Metab."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.fertnstert.2007.12.018","article-title":"Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders","volume":"89","author":"Dokras","year":"2008","journal-title":"Fertil Steril."},{"key":"B86","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: Systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"Br Med J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1111\/1471-0528.14764","article-title":"13","volume":"124","year":"2017","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub6","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1471-0528.14754","article-title":"Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials","volume":"125","author":"Pundir","year":"2018","journal-title":"BJOG An Int J Obstet Gynaecol."},{"key":"B90","first-page":"2620","article-title":"Advances in aromatase inhibition:clinical efficacy and tolerability in the treatment of breast cancer","volume":"7","author":"Buzdar","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1200\/JCO.2002.06.020","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: Status report 2002","volume":"20","author":"Winer","year":"2002","journal-title":"J Clin Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1043-2760(02)00567-2","article-title":"Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans","volume":"13","author":"Kamat","year":"2002","journal-title":"Trends Endocrinol Metab."},{"key":"B93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-4731(88)90093-3","article-title":"The cellular effects of estrogens on neuroendocrine tissues","volume":"30","author":"Naftolin","year":"1988","journal-title":"J Steroid Biochem."},{"key":"B94","first-page":"257","article-title":"Brain aromatization of androgens","volume":"39","author":"Naftolin","year":"1994","journal-title":"J Reprod Med Obstet Gynecol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril."},{"key":"B96","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril."},{"key":"B97","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/uog.18933","article-title":"Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis","volume":"51","author":"Gadalla","year":"2018","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1210\/jcem-23-2-181","article-title":"Clinical effect of human urinary postmenopausal gonado-tropin","volume":"23","author":"Rosemberg","year":"1963","journal-title":"J Clin Endocrinol Metab."},{"key":"B99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/S12522-011-0097-2","article-title":"Gonadotropin stimulation: past, present and future","volume":"11","author":"Lunenfeld","year":"2012","journal-title":"Reprod Med Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.fertnstert.2008.08.031","article-title":"Gonadotropin preparations: past, present, and future perspectives","volume":"90","author":"Birmingham","year":"2008","journal-title":"Fertil Steril."},{"key":"B101","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1472-6483(10)61155-8","article-title":"Are recombinant gonadotrophins safer, purer and more effective than urinary gonadotrophins?","volume":"11","author":"Casper","year":"2005","journal-title":"Reprod Biomed Online."},{"key":"B102","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/humupd\/dmh044","article-title":"Historical perspectives in gonadotrophin therapy","volume":"10","author":"Lunenfeld","year":"2004","journal-title":"Hum Reprod Update."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1210\/jcem.83.5.4770","article-title":"Recombinant human Luteinizing Hormone (LH) to support recombinant human Follicle-Stimulating Hormone (FSH)-Induced Follicular Development in LH- and FSH-Deficient anovulatory women: a dose-finding study1","volume":"83","author":"Group","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/OXFORDJOURNALS.HUMREP.A138685","article-title":"Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women","volume":"9","author":"Schoot","year":"1994","journal-title":"Hum Reprod."},{"key":"B105","doi-asserted-by":"publisher","first-page":"CD010290","DOI":"10.1002\/14651858.CD010290.pub2","article-title":"Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome","volume":"1","author":"Weiss","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B106","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0015-0282(16)49634-2","article-title":"Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin","volume":"46","author":"Chong","year":"1986","journal-title":"Fertil Steril."},{"key":"B107","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0015-0282(16)47534-5","article-title":"Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope","volume":"41","author":"Gjonnaess","year":"1984","journal-title":"Fertil Steril."},{"key":"B108","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s13224-017-1010-7","article-title":"Unilateral versus bilateral laparoscopic ovarian drilling using thermal dose adjusted according to ovarian volume in CC-resistant PCOS, a randomized study","volume":"67","author":"El-Sayed","year":"2017","journal-title":"J Obstet Gynecol India."},{"key":"B109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.22074\/ijfs.2015.4202","article-title":"Comparison between unilateral and bilateral ovarian drilling in clomiphene citrate resistance polycystic ovary syndrome patients: A randomized clinical trial of efficacy","volume":"9","author":"Sorouri","year":"2015","journal-title":"Int J Fertil Steril."},{"key":"B110","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0015-0282(16)60482-X","article-title":"Polycystic ovaries treated by laparoscopic laser vaporization","volume":"51","author":"Daniell","year":"1989","journal-title":"Fertil Steril."},{"key":"B111","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/s0015-0282(16)57408-1","article-title":"Surgically induced ovulation in the polycystic ovary syndrome: Wedge resection revisited in the age of laparoscopy","volume":"63","author":"Donesky","year":"1995","journal-title":"Fertil Steril."},{"key":"B112","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/s0015-0282(16)56273-6","article-title":"Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: Lack of correlation with pregnancy rate","volume":"60","author":"Greenblatt","year":"1993","journal-title":"Fertil Steril."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0015-0282(16)54737-2","article-title":"Evaluation of adhesion formation after laparoscopic treatment of polycystic ovarian disease","volume":"56","author":"Gurgan","year":"1991","journal-title":"Fertil Steril."},{"key":"B114","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/s0015-0282(16)56042-7","article-title":"Laparoscopic electrocoagulation of the ovarian surface in infertile patients with polycystic ovarian disease","volume":"60","author":"Naether","year":"1993","journal-title":"Fertil Steril."},{"key":"B115","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0015-0282(16)56043-9","article-title":"Adhesion formation after laparoscopic electrocoagulation of the ovarian surface in polycystic ovary patients","volume":"60","author":"Naether","year":"1993","journal-title":"Fertil Steril."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.982230\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T05:34:06Z","timestamp":1660282446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.982230\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":115,"alternative-id":["10.3389\/fmed.2022.982230"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.982230","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"article-number":"982230"}}